Dolutegravir + Lamivudine
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Dolutegravir
dolutegravir - Lamivudine
lamivudine
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| DovatoAUCAESEUGBHKMXSGTWUS | 50 mg / 300 mg | Viiv Healthcare B.V. |
| Dolutegravir 50mg / Lamivudine 300mg tabletsAUESGB | 50 mg / 300 mg | Viiv Healthcare B.V. |
| dolutegravir + lamivudinaES | 50 mg / 300 mg | Viiv Healthcare B.V. |
| dolutegravir sodium and lamivudineUS | 50 mg / 300 mg | ViiV Healthcare Company |
| lamivudine + dolutegravir sodiumAU | — | — |
| 洛瓦梭膜衣錠TW | — | 荷商葛蘭素史克藥廠股份有限公司台灣分公司 |
| DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottleAU | 300 mg / 52.6 mg | ViiV Healthcare Pty Ltd |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- CA · DOVATO · 1 products · record
- ES · DOVATO · 1 products · record
- GB · DOVATO · 1 products · record
- US · DOVATO · 1 products · record
- AU · DOVATO · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.